يعرض 1 - 10 نتائج من 57 نتيجة بحث عن '"Melphalan-flufenamide"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: Drug Design, Development and Therapy, Vol Volume 15, Pp 2969-2978 (2021)

    وصف الملف: electronic resource

    العلاقة: https://www.dovepress.com/spotlight-onTest-melphalan-flufenamide-an-up-and-coming-therapy-for-the-tr-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881Test

  3. 3
    دورية أكاديمية

    المساهمون: Institute for Molecular Medicine Finland, University of Helsinki, Helsinki Institute of Life Science HiLIFE, Research Programs Unit, Digital Precision Cancer Medicine (iCAN)

    وصف الملف: application/pdf

    العلاقة: This research was funded by the Academy of Finland, Centre of Excellence in Body-on-aChip research (grant numbers 312413, 326588, 336666 and 336785), Business Finland, YCompetitive State Research Financing of the Expert Responsibility area of Tampere University Hospital, and Finnish National Agency for Education.; Gebraad , A , Ohlsbom , R , Miettinen , J J , Emeh , P , Pakarinen , T-K , Manninen , M , Eskelinen , A , Kuismanen , K , Slipicevic , A , Lehmann , F , Nupponen , N N , Heckman , C A & Miettinen , S 2022 , ' Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen ' , Cells , vol. 11 , no. 9 , 1574 . https://doi.org/10.3390/cells11091574Test; ORCID: /0000-0002-3987-1693/work/113985832; 4c5cf765-fadd-4e8c-907e-c6ae4c623819; http://hdl.handle.net/10138/344210Test; 000794431900001

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: Larocca A., Leleu X., Touzeau C., Blade J., Paner A., Mateos M.-V., Cavo M., Maisel C., Alegre A., Oriol A., Raptis A., Rodriguez-Otero P., Mazumder A., Laubach J., Nadeem O., Sandberg A., Orre M., Torrang A., Bakker N.A., Richardson P.G.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34671975; info:eu-repo/semantics/altIdentifier/wos/WOS:000709242300001; volume:196; issue:3; firstpage:639; lastpage:648; numberofpages:10; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/2318/1846953Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117392564; https://doi.org/10.1111/bjh.17887Test

  8. 8
  9. 9
    دورية أكاديمية

    المساهمون: F. Morabito, G. Tripepi, E.A. Martino, E. Vigna, F. Mendicino, L. Morabito, K. Todoerti, H. Al-Janazreh, G. D'Arrigo, F.A. Canale, G. Cutrona, A. Neri, M. Martino, M. Gentile

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34262262; info:eu-repo/semantics/altIdentifier/wos/WOS:000671357500001; volume:15; firstpage:2969; lastpage:2978; numberofpages:10; journal:DRUG DESIGN, DEVELOPMENT AND THERAPY; http://hdl.handle.net/2434/860025Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85110925941

  10. 10
    دورية أكاديمية

    المصدر: Bringhen , S , Voorhees , P M , Plesner , T , Mellqvist , U-H , Reeves , B , Sonneveld , P , Byrne , C , Nordström , E , Harmenberg , J , Obermüller , J & Richardson , P G 2021 , ' Melflufen plus dexamethasone in relapsed/refractory multiple myeloma : long-term survival follow-up from the Phase II study O-12-M1 ' , British Journal of Haematology , vol. 193 , no. 6 , pp. 1105-1109 . https://doi.org/10.1111/bjh.17302Test

    وصف الملف: application/pdf